-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App, Cinda Biotech (01801.HK) announced that its partner Ollin Biosciences, Inc. (Ollin) has reached an acquisition agreement with Johnson & Johnson (NYSE: JNJ). The Ollin core pipeline OLN324 (Cinda Biotech R&D code: IBI324) was developed by Cinda Biotech and authorized to the outside world.

Zhitongcaijing·11/16/2026 14:25:10
Listen to the news
According to Zhitong Finance App, Cinda Biotech (01801.HK) announced that its partner Ollin Biosciences, Inc. (Ollin) has reached an acquisition agreement with Johnson & Johnson (NYSE: JNJ). The Ollin core pipeline OLN324 (Cinda Biotech R&D code: IBI324) was developed by Cinda Biotech and authorized externally.